Chronic, recurrent Lymphocytic Leukemia Suspended Phase 1 Trials for Rimiducid (DB04974)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Suspended1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03807063Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantTreatment